U.S. appeals court upholds MIT, Harvard patents on CRISPR gene editing | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

U.S. appeals court upholds MIT, Harvard patents on CRISPR gene editing


A U.S. appeals court on Monday allowed a research center affiliated with the Massachusetts Institute of Technology and Harvard University to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR.

The U.S. Court of Appeals for the Federal Circuit affirmed the validity of the Harvard and MIT patents, rejecting a challenge brought by a rival team of researchers associated with the University of California at Berkeley and University of Vienna in Austria.

https://www.duchennexchange.org/wp-content/uploads/2018/09/Screen-Shot-2018-09-11-at-11.16.33-AM.png